Scope & Limitations

Scope of the Program

The Continuity Program accepts a broad range of academic and scholarly manuscripts from researchers worldwide. Submissions are evaluated on the basis of academic rigor, originality, and relevance regardless of the author's country of origin or institutional affiliation.

Accepted Manuscript Types

• Original research articles
• Systematic and narrative review articles
• Undergraduate and graduate theses
• Doctoral dissertations
• Case studies
• Conference papers
• Technical and policy reports with academic grounding

Accepted Subject Areas

The program is multidisciplinary and accepts manuscripts from all academic fields, including but not limited to:

Limitations

What the Program Does Not Accept

• Manuscripts previously published in peer-reviewed journals without the author retaining distribution rights
• Works that plagiarize, misrepresent, or replicate existing research without proper attribution
• Manuscripts containing fabricated data or fraudulent findings
• Content that promotes discrimination, harm, or violates ethical research standards
• Commercial materials, marketing content, or non-academic works
• Manuscripts submitted without the consent of all listed authors

Platform Limitations

• The Continuity Program is not a journal publisher. Manuscripts made available here are not automatically indexed in external academic databases (e.g., Scopus, PubMed).
• The platform does not currently offer DOI registration for all manuscripts — this is subject to change.
• Royalty payouts are subject to minimum thresholds and monthly processing cycles. Plethoryt is not liable for delays due to payment processor issues.
• The platform does not guarantee approval. All submissions are subject to editorial screening and reviewer evaluation.
• Royalty Plan manuscripts are subject to a minimal processing fee applied after approval — not at submission. Submission is always free for all access types.

Intellectual Property

Authors retain copyright to their manuscripts. By submitting, authors grant the Continuity Program a non-exclusive, worldwide license to host, display, and make available their work in accordance with the access type selected (Open Access or Royalty Plan). Authors who choose Open Access grant readers a license to read and cite the work freely, subject to proper attribution.